Resultados de la búsqueda 941-950 of 9715 for monoclonal antibody
Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients ...
* Whether the body makes antibodies against the study drug(s) (which ... antibody) * Olaparib (a type of PARP inhibitor). A Study To Assess Adverse ...
The purpose of this study is to study the handling of ovarian tissue, cryopreservation technology, and oocyte maturation for female pediatric cancer ...
Antineuronal Antibody Positivity Prevalence And Predictors In Epilepsy With Different Risks Of Autoimmune Epilepsy. Rochester, Minn. The purpose of this ...
... antibody) * Olaparib (a type of PARP inhibitor). A Study To Examine The Effects Of Novel Therapy Linvoseltamab In Combination With Other Cancer Treatments ...
This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...
* Whether the body makes antibodies against the study drug(s) (which could make the study drug(s) less effective or could lead to side effects). Assessing ...
Also want to find out if kidney tumor treatment leads to an improvement in these immune markers. A Study of Hematopoiesis in Patients with Monoclonal B Cell ...
For various rare immunobullous diseases, detection of a circulating autoantibody is necessary for accurate diagnosis. As a CLIA requirement, every clinical ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?